(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BLUESPHERE BIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BLUESPHERE BIO

ST13

US500000088244187

Class

42, 44

Filing

88244187

Registration

6195846

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

11/11/2025

Trademark type

Word

Nice classes

42, 44

Filing date

12/28/2018

Registration date

11/10/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/10/2020

Last transaction

11/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/30/2019

First use in commerce

07/30/2019

Drawing code

4

Owner type

03

Owner location

PITTSBURGH, PA

Examiner

MCPHERSON RAYBURN,SHAVELL A

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BLUESPHERE BIO, INC.
UPMC

Representatives

Tracey Beiriger UPMC

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

scientific research and development services for direct cloning and screening T-cell receptors from single T-cells for desired specificities such as anti-tumortransducing them into primary T-cells for therapeutic use

Class 44

medical treatment servicesthe administration of gene therapy to patients involving harvesting a patient's cellscloning their T-cell receptors from single cellsscreening these receptors for desired specificities such as anti-tumortransducing them into primary T-cellsre-administration of the transduced T-cells back into the patient

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/10/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/24/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

11/10/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/03/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/02/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/11/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/11/2020

IUAF

USE AMENDMENT FILED

08/26/2020

EISU

TEAS STATEMENT OF USE RECEIVED

08/26/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/03/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

01/23/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/10/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2019

PUBO

PUBLISHED FOR OPPOSITION

11/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2019

ALIE

ASSIGNED TO LIE

10/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/04/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/04/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/04/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/21/2019

GNRT

NON-FINAL ACTION E-MAILED

03/21/2019

CNRT

NON-FINAL ACTION WRITTEN

03/21/2019

DOCK

ASSIGNED TO EXAMINER

03/19/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/19/2019

NWAP

NEW APPLICATION ENTERED

01/01/2019

Continuous trademark protection

Get notified about every new filing that threatens BLUESPHERE BIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.